Home  |  Contact

Cellosaurus OMC-1 [Human ovarian carcinoma] (CVCL_9T73)

[Text version]
Cell line name OMC-1 [Human ovarian carcinoma]
Accession CVCL_9T73
Resource Identification Initiative To cite this cell line use: OMC-1 [Human ovarian carcinoma] (RRID:CVCL_9T73)
Comments Population: Japanese.
Doubling time: 24 hours (DOI=10.15114/smj.55.153).
Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
Disease Ovarian mucinous cystadenocarcinoma (NCIt: C4026)
Mucinous adenocarcinoma of ovary (ORDO: Orphanet_398961)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 75Y
Category Cancer cell line
Publications

DOI=10.15114/smj.55.153
Hayakawa O., Tsumura N., Koizumi M., Endo T., Kudo R.
Establishment and characterization of cell line (OMC-1) derived from mucinous cystadenocarcinoma of human ovary.
Sapporo Igaku Zasshi 55:153-160(1986)

PubMed=19154404; DOI=10.1111/j.1349-7006.2008.01065.x
Sato S., Itamochi H., Kigawa J., Oishi T., Shimada M., Sato S., Naniwa J., Uegaki K., Nonaka M., Terakawa N.
Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Cancer Sci. 100:546-551(2009)

PubMed=22246397; DOI=10.3892/or.2012.1626
Sato N., Saga Y., Mizukami H., Wang D., Fujiwara H., Takei Y., Machida S., Ozawa K., Suzuki M.
Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations.
Oncol. Rep. 27:1336-1340(2012)

Cross-references
Encyclopedic resources Wikidata; Q54932032
Polymorphism and mutation databases Cosmic; 2429302
Entry history
Entry creation23-Feb-2016
Last entry update29-Jun-2023
Version number9